Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
ACVA ACV Auctions	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.65	$20.00 ➝ $21.00
ADTN ADTRAN	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.55 -0.4%	$15.00 ➝ $12.00
ADTN ADTRAN	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.55 -0.4%	$12.00 ➝ $11.00	Buy
AFL Aflac	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.67 -1.8%	$69.00 ➝ $76.00
AGTI Agiliti	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.27 -28.0%	$23.00 ➝ $20.00	Overweight
AKAM Akamai Technologies	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.99 +8.5%	$93.00 ➝ $113.00
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
AKAM Akamai Technologies	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.99 +8.5%	$105.00 ➝ $115.00
AKAM Akamai Technologies	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.99 +8.5%	$100.00 ➝ $118.00
AKAM Akamai Technologies	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.99 +8.5%	$85.00 ➝ $97.00
AKYA Akoya Biosciences	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.15 -5.5%	$16.00 ➝ $14.00
ALE ALLETE	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.16 -0.6%	$64.00 ➝ $58.00
AMPH Amphastar Pharmaceuticals	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$62.21 -4.3%	$66.00 ➝ $71.00
AMPL Amplitude	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.41 +6.7%	$12.00 ➝ $13.00
AMRC Ameresco	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.95 -1.0%	$66.00 ➝ $64.00
ARKO Arko	Initiated by	Odeon Capital Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.20 +2.8%	$11.00	Buy
ARVN Arvinas	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.84 -1.9%	$81.00 ➝ $70.00
ASLE AerSale	Downgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.93 -25.1%	$20.00 ➝ $15.00	Outperform ➝ Sector Perform
ATKR Atkore	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$149.55 -3.8%	$178.00 ➝ $186.00
ATSG Air Transport Services Group	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.43 -1.2%	$18.00 ➝ $26.00
AVA Avista	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.73 -0.1%	$38.00 ➝ $36.00
AVID Avid Technology	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.55 -1.4%	$25.00 ➝ $27.00
AXS AXIS Capital	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.65 -0.6%	$59.00 ➝ $61.00
AZEK AZEK	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.25 +6.4%	$39.00 ➝ $41.00
AZEK AZEK	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.25 +6.4%	$32.00 ➝ $40.00
AZEK AZEK	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.25 +6.4%	$30.00 ➝ $40.00
AZTA Azenta	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.76 +20.3%	$45.00 ➝ $55.00
AZTA Azenta	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.76 +20.3%	$55.00 ➝ $65.00
BEAM Beam Therapeutics	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.11 -0.5%	$60.00 ➝ $56.00
BEP Brookfield Renewable Partners	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.43 -1.4%	$32.00 ➝ $27.00
BHIL Benson Hill	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.99 -21.1%		Outperform ➝ Market Perform
BITF Bitfarms	Target Raised by	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.53 -5.6%	$4.50 ➝ $5.00
BKH Black Hills	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.68 +0.6%	$60.00 ➝ $56.00
BL BlackLine	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.93 -6.8%	$55.00 ➝ $53.00
BL BlackLine	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.93 -6.8%	$80.00 ➝ $70.00
BL BlackLine	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.93 -6.8%	$87.00 ➝ $81.00
BLFS BioLife Solutions	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.11 -28.7%	$34.00 ➝ $25.00
BLFS BioLife Solutions	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.11 -28.7%	$29.00 ➝ $22.00
BMBL Bumble	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.61 -7.7%	$27.00 ➝ $23.00	Outperform
BR Broadridge Financial Solutions	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$178.58 +1.0%	$160.00 ➝ $164.00
BR Broadridge Financial Solutions	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$178.58 +1.0%	$169.00 ➝ $190.00

BRO Brown & Brown	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$70.65 +0.6%	$72.00 ➝ $81.00
BROS Dutch Bros	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.01 +17.9%	$37.00	Outperform
BSY Bentley Systems	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.85 -5.5%		Outperform ➝ Market Perform
BVS Bioventus	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.09 +5.4%	$4.00 ➝ $6.00	Hold ➝ Buy
BXP Boston Properties	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.07 -2.3%	$64.00 ➝ $80.00
CCCC C4 Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.46 -1.4%	$25.00 ➝ $17.00
CE Celanese	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.25 +0.7%	$135.00 ➝ $122.00	Overweight ➝ Neutral
CE Celanese	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.25 +0.7%	$130.00 ➝ $140.00
CELH Celsius	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Pascarelli Subscribe to MarketBeat All Access for the recommendation accuracy rating	$172.67 +20.4%	$155.00 ➝ $180.00
CELH Celsius	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.67 +20.4%	$165.00 ➝ $191.00
CELH Celsius	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.67 +20.4%	$180.00 ➝ $200.00
CELH Celsius	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.67 +20.4%	$165.00 ➝ $185.00
CELH Celsius	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$172.67 +20.4%	$165.00 ➝ $180.00
CHGG Chegg	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.13 -3.2%	$10.00 ➝ $12.00
CHH Choice Hotels International	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.06 +1.2%	$135.00 ➝ $142.00
CHH Choice Hotels International	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.06 +1.2%	$122.00 ➝ $121.00
CHH Choice Hotels International	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.06 +1.2%	$115.00 ➝ $123.00
CI The Cigna Group	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$288.33 -1.3%	$284.00 ➝ $300.00
CLBT Cellebrite DI	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.99 -0.5%	$6.50 ➝ $9.00
CLPT ClearPoint Neuro	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.22 -2.8%	$22.00 ➝ $15.00
CMCSA Comcast	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$45.28 -0.3%	$45.00 ➝ $50.00
CP Canadian Pacific Kansas City	Target Raised by	CSFB Subscribe to MarketBeat All Access for the recommendation accuracy rating		$81.17 +0.5%	$87.00 ➝ $88.00	Neutral
CPNG Coupang	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.27 +7.7%	$20.00	Buy ➝ Hold
CPNG Coupang	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.27 +7.7%	$20.00 ➝ $22.00
CRBG Corebridge Financial	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.43 -5.0%	$19.00 ➝ $20.00
CRNX Crinetics Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Tsao Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.68 -3.6%	$35.00 ➝ $33.00
CRNX Crinetics Pharmaceuticals	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.68 -3.6%	$43.00 ➝ $42.00
CRNX Crinetics Pharmaceuticals	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.68 -3.6%	$48.00 ➝ $43.00
CTMX CytomX Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.63 -3.6%	$2.00	Neutral
CTOS Custom Truck One Source	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.74 +1.8%	$9.00 ➝ $11.00
CUTR Cutera	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.38 -22.5%	$42.00 ➝ $33.00
CVX Chevron	Target Raised by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$159.86 +0.1%	$180.00 ➝ $184.00
DADA Dada Nexus	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.60 -1.8%	$13.00 ➝ $10.00
DBTX Decibel Therapeutics	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.03 +80.3%		Buy ➝ Neutral
DCPH Deciphera Pharmaceuticals	Upgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.74 +6.2%		Hold ➝ Buy
DDOG Datadog	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.76 -1.5%	$87.00 ➝ $100.00
DDOG Datadog	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.76 -1.5%	$118.00 ➝ $103.00
DDOG Datadog	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.76 -1.5%	$130.00 ➝ $120.00
DDOG Datadog	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.76 -1.5%	$112.00 ➝ $98.00
DE Deere & Company	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$436.09 +1.3%	$392.00 ➝ $398.00
DEO Diageo	Target Lowered by	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$171.46 +0.3%	GBX 3,850 ➝ GBX 3,800
DIOD Diodes	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$81.14 -5.2%	$100.00 ➝ $95.00
DKNG DraftKings	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.26 -10.9%	$26.00	Underweight ➝ Neutral
DKNG DraftKings	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.26 -10.9%	$30.00 ➝ $41.00
DNLI Denali Therapeutics	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.73 -4.3%	$37.00 ➝ $31.00
DOCS Doximity	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.30 -22.8%	$33.00 ➝ $28.00
DOCS Doximity	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.30 -22.8%		Buy ➝ Neutral
DOCS Doximity	Downgraded by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.30 -22.8%		Buy ➝ Hold
DOCS Doximity	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.30 -22.8%	$36.00 ➝ $27.00
DOCS Doximity	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.30 -22.8%	$28.00 ➝ $24.00

DUK Duke Energy	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.82 +0.7%	$105.00 ➝ $98.00
DUOL Duolingo	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$144.91 +6.6%	$136.00 ➝ $149.00
DUOL Duolingo	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$144.91 +6.6%	$167.00 ➝ $170.00
EDR Endeavor Group	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.03 +6.1%	$33.00 ➝ $35.00
EG Everest Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$359.00 +3.7%	$406.00 ➝ $408.00
EGHT 8X8	Downgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.30 -21.6%	$7.00 ➝ $4.00	Buy ➝ Hold
EGRX Eagle Pharmaceuticals	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.23 -16.0%	$26.00 ➝ $17.00	Neutral ➝ Underweight
EHTH eHealth	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.98 +1.2%	$5.00 ➝ $10.00
ENR Energizer	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.06 +6.8%	$43.00 ➝ $40.00
ENTA Enanta Pharmaceuticals	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.70 -9.8%	$14.00	Neutral ➝ Underweight
EQNR Equinor ASA	Upgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.54 +5.4%		Sector Perform ➝ Outperform
ESE ESCO Technologies	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.36 +2.7%	$110.00 ➝ $120.00
EVBG Everbridge	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.78 -4.4%	$30.00 ➝ $26.00
EVBG Everbridge	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.78 -4.4%	$27.00 ➝ $25.00
EXFY Expensify	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.23 -28.5%	$10.00 ➝ $7.00
EXFY Expensify	Downgraded by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.23 -28.5%	$9.00 ➝ $6.00	Buy ➝ Hold
EXFY Expensify	Downgraded by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.23 -28.5%		Outperform ➝ Market Perform
EXFY Expensify	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.23 -28.5%	$10.00 ➝ $8.00
EXK Endeavour Silver	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.02	C$5.50 ➝ C$5.00
EXK Endeavour Silver	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Heiko Ihle Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.02	$8.00 ➝ $7.75
EXPD Expeditors International of Washington	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$117.37 -1.6%	$104.00 ➝ $115.00
EXPD Expeditors International of Washington	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$117.37 -1.6%	$105.00 ➝ $115.00
FLT FLEETCOR Technologies	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.04 +6.3%	$230.00 ➝ $245.00
FLT FLEETCOR Technologies	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.04 +6.3%	$240.00 ➝ $277.00
FLT FLEETCOR Technologies	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.04 +6.3%	$310.00 ➝ $300.00
FLYW Flywire	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.17 +6.2%	$34.00 ➝ $37.00
FLYW Flywire	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.17 +6.2%	$34.00 ➝ $43.00
FNF Fidelity National Financial	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.77 +2.8%	$47.00 ➝ $48.00
GBDC Golub Capital BDC	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.02 +4.5%	$15.50	Market Perform ➝ Outperform
GDRX GoodRx	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.94 -9.2%	$6.00 ➝ $7.00
GFS GLOBALFOUNDRIES	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.21 -1.5%	$77.00 ➝ $70.00
GFS GLOBALFOUNDRIES	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.21 -1.5%	$75.00 ➝ $70.00
GFS GLOBALFOUNDRIES	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.21 -1.5%	$65.00 ➝ $64.00
GFS GLOBALFOUNDRIES	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.21 -1.5%	$72.00 ➝ $70.00	Outperform
GFS GLOBALFOUNDRIES	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.21 -1.5%	$70.00 ➝ $65.00	Buy
GFS GLOBALFOUNDRIES	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.21 -1.5%	$80.00 ➝ $73.00	Overweight
GO Grocery Outlet	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.59 +4.4%	$29.00 ➝ $38.00
GO Grocery Outlet	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.59 +4.4%	$38.00 ➝ $39.00
GOLD Barrick Gold	Upgraded by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.46 +0.1%		Market Perform ➝ Buy
GRWG GrowGeneration	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.80 -22.9%	$6.00 ➝ $5.00
GTLS Chart Industries	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$167.03 +0.8%	$162.00 ➝ $224.00	Equal Weight ➝ Overweight
HAE Haemonetics	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$90.43 +0.5%	$111.00 ➝ $114.00
HALO Halozyme Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.63 -1.6%	$61.00 ➝ $60.00
HALO Halozyme Therapeutics	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.63 -1.6%	$46.00 ➝ $48.00
HCI HCI Group	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.18 +6.0%	$75.00 ➝ $80.00
HCKT The Hackett Group	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.73 +2.2%	$24.00 ➝ $28.00
HIG The Hartford Financial Services Group	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.84 -0.3%	$87.00 ➝ $85.00
HIMS Hims & Hers Health	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.32 -1.6%	$12.00 ➝ $10.00
HIPO Hippo	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.25 -10.5%	$70.00 ➝ $50.00
HNI HNI	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.49 +11.7%	$36.00 ➝ $45.00

IDA IDACORP	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$97.75 -1.0%	$107.00 ➝ $105.00
IFF International Flavors & Fragrances	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.78 -1.5%	$110.00 ➝ $85.00
IFF International Flavors & Fragrances	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.78 -1.5%	$120.00 ➝ $78.00	Buy ➝ Neutral
IFF International Flavors & Fragrances	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.78 -1.5%	$84.00 ➝ $70.00
IFF International Flavors & Fragrances	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.78 -1.5%	$93.00 ➝ $80.00
IFF International Flavors & Fragrances	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.78 -1.5%	$83.00 ➝ $67.00
IFF International Flavors & Fragrances	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.78 -1.5%	$106.00 ➝ $75.00
INGR Ingredion	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.06 +0.0%	$125.00 ➝ $117.00
IOVA Iovance Biotherapeutics	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.60 +6.4%	$23.00 ➝ $20.00
IPSC Century Therapeutics	Target Lowered by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.85 -1.7%	$19.00 ➝ $17.00
ITOS iTeos Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.13 -0.3%	$54.00 ➝ $44.00
J Jacobs Solutions	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$136.37 +1.5%	$135.00 ➝ $150.00
JAMF Jamf	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.74 -15.7%	$25.00 ➝ $22.00
JAMF Jamf	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.74 -15.7%	$24.00 ➝ $23.00
JRVR James River Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.62 -4.0%	$18.00 ➝ $17.00
KNF Knife River	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.94 -3.0%	$54.00 ➝ $58.00
LCII LCI Industries	Downgraded by	CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$125.11 +0.2%		Outperform ➝ Market Perform
LLY Eli Lilly and Company	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$526.23 +0.9%	$500.00 ➝ $590.00
LLY Eli Lilly and Company	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$526.23 +0.9%	$500.00 ➝ $600.00
LLY Eli Lilly and Company	Target Raised by	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$526.23 +0.9%	$490.00 ➝ $580.00
LLY Eli Lilly and Company	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$526.23 +0.9%	$510.00 ➝ $600.00
LLY Eli Lilly and Company	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$526.23 +0.9%	$525.00 ➝ $600.00
LLY Eli Lilly and Company	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$526.23 +0.9%	$565.00 ➝ $633.00
LNW Light & Wonder	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.51 +3.3%	$81.00 ➝ $86.00
LPRO Open Lending	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.96 -22.3%	$12.00 ➝ $11.00
LPSN LivePerson	Upgraded by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.75 +19.0%	$6.00	Neutral ➝ Buy
LPSN LivePerson	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.75 +19.0%	$7.00	Hold ➝ Buy
LVLU Lulu's Fashion Lounge	Downgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.28 -6.9%	$4.00 ➝ $3.00	Outperform ➝ Neutral
LYB LyondellBasell Industries	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.34 +0.9%	$121.00 ➝ $116.00
LYFT Lyft	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.40 -10.0%	$9.00 ➝ $12.00
LYFT Lyft	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.40 -10.0%	$10.00 ➝ $12.00
LYFT Lyft	Target Lowered by	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.40 -10.0%	$23.00 ➝ $18.00
LZ LegalZoom.com	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.21 -20.5%	$12.00 ➝ $17.00
LZ LegalZoom.com	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.21 -20.5%	$15.00 ➝ $17.00
MAPS WM Technology	Upgraded by	Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.14 -5.0%		Hold ➝ Buy
MARA Marathon Digital	Target Lowered by	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.51 -1.3%	$21.00 ➝ $20.00
MASI Masimo	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$117.96 -1.7%	$126.00 ➝ $110.00
MDGL Madrigal Pharmaceuticals	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.73 -0.2%	$350.00 ➝ $285.00
MDXG MiMedx Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.44 +1.5%	$12.00 ➝ $14.00
MELI MercadoLibre	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1,312.66 -1.2%	$1,500.00 ➝ $1,550.00
MET MetLife	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$62.63 -1.4%	$76.00 ➝ $81.00
MNDY monday.com	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$152.49 -1.3%	$160.00 ➝ $180.00
MODG Topgolf Callaway Brands	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.96 -7.1%	$32.00 ➝ $26.00
MODG Topgolf Callaway Brands	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.96 -7.1%	$33.00 ➝ $26.00
MODG Topgolf Callaway Brands	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.96 -7.1%	$30.00 ➝ $25.00
MODN Model N	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.06 -12.0%	$38.00 ➝ $33.00
MODN Model N	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.06 -12.0%	$47.00 ➝ $37.00
MODN Model N	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.06 -12.0%	$40.00 ➝ $35.00
MODN Model N	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.06 -12.0%	$52.00 ➝ $40.00
MQ Marqeta	Upgraded by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.54 +11.7%	$5.00 ➝ $8.00	Hold ➝ Buy

MRTX Mirati Therapeutics	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.00 +33.1%	$56.00 ➝ $62.00
MRTX Mirati Therapeutics	Upgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.00 +33.1%	$45.00	Neutral ➝ Buy
MRTX Mirati Therapeutics	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.00 +33.1%	$77.00 ➝ $83.00
MRTX Mirati Therapeutics	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.00 +33.1%	$40.00 ➝ $31.00
MRTX Mirati Therapeutics	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.00 +33.1%	$45.00	Overweight
MSFT Microsoft	Target Set by	Fundamental Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$322.23 -1.2%	$298.10	Hold
MTTR Matterport	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.69 -14.5%	$3.00 ➝ $3.50
NEO NeoGenomics	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.82 -3.3%	$20.00 ➝ $18.00
NRDY Nerdy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.16 -18.8%	$3.50 ➝ $5.00
NRDY Nerdy	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.16 -18.8%	$6.00 ➝ $8.00
NSPR InspireMD	Target Raised by	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.10	$4.75 ➝ $5.20
NTES NetEase	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$107.40 +0.4%	$118.00 ➝ $134.00
NVAX Novavax	Upgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Mamtani Subscribe to MarketBeat All Access for the recommendation accuracy rating	$7.12 -1.5%	$15.00	Neutral ➝ Buy
NVDA NVIDIA	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$425.54 -4.7%	$370.00 ➝ $440.00	Hold
NVEI Nuvei	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$18.13 -39.4%		Buy ➝ Neutral
NWE NorthWestern	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.23 -0.3%	$60.00 ➝ $59.00
NYT New York Times	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.89 -0.9%	$36.00 ➝ $37.00
OCS Oculis	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.00 +2.0%	$28.00 ➝ $29.00
OCS Oculis	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.00 +2.0%	$58.00 ➝ $64.00
OLPX Olaplex	Downgraded by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.80 -13.3%	$6.00 ➝ $4.00	Outperform ➝ Market Perform
OLPX Olaplex	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.80 -13.3%	$15.00 ➝ $7.00
PALI Palisade Bio	Downgraded by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.72 -62.7%		Buy ➝ Hold
PANW Palo Alto Networks	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$213.47 +0.9%	$307.00 ➝ $259.00
PAYO Payoneer Global	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.77 +2.1%	$9.00 ➝ $10.00
PDFS PDF Solutions	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.36 -12.9%	$45.00 ➝ $48.00
PETQ PetIQ	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.82 +8.1%	$20.00 ➝ $25.00
PHAT Phathom Pharmaceuticals	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.13 +2.8%	$28.00	Buy
PODD Insulet	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$229.69 -3.6%	$360.00 ➝ $325.00
PODD Insulet	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$229.69 -3.6%	$375.00 ➝ $330.00
PODD Insulet	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$229.69 -3.6%	$319.00 ➝ $273.00
PODD Insulet	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$229.69 -3.6%	$370.00 ➝ $320.00
PRI Primerica	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$213.48 -0.7%	$240.00 ➝ $260.00
PSNL Personalis	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.99 +0.5%	$10.00 ➝ $7.50
PSTX Poseida Therapeutics	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.73 +37.9%	$17.00 ➝ $14.00
PUBM PubMatic	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.30 -33.7%		Outperform ➝ Market Perform
PUBM PubMatic	Downgraded by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.30 -33.7%	$23.00 ➝ $16.00	Outperform ➝ Neutral
PWFL PowerFleet	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.18 -5.2%	$5.00 ➝ $4.00
QGEN Qiagen	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.74 +0.3%	$50.00 ➝ $48.00
QMCO Quantum	Downgraded by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.70 -2.8%		Outperform ➝ Market Perform
QSR Restaurant Brands International	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$82.00 ➝ $85.00	Buy
QSR Restaurant Brands International	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$76.00 ➝ $78.00	Equal Weight
QSR Restaurant Brands International	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$74.00 ➝ $80.00	Neutral
QSR Restaurant Brands International	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$89.00 ➝ $90.00	Buy
QSR Restaurant Brands International	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$81.00 ➝ $82.00	Sector Outperform
QSR Restaurant Brands International	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$87.00 ➝ $88.00	Outperform
QSR Restaurant Brands International	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$84.00 ➝ $86.00	Overweight
QSR Restaurant Brands International	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$86.00 ➝ $88.00	Outperform
QSR Restaurant Brands International	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$81.00 ➝ $88.00	Outperform
QSR Restaurant Brands International	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$85.00 ➝ $83.00	Neutral
QSR Restaurant Brands International	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$73.00 ➝ $75.00	Hold
QSR Restaurant Brands International	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.28 -1.4%	$73.00 ➝ $79.00	Underperform
RAIL FreightCar America	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.94 -4.9%	$3.00 ➝ $3.50
RBC RBC Bearings	Upgraded by	Alembic Global Advisors Subscribe to MarketBeat All Access for the recommendation accuracy rating		$225.93 -0.1%	$267.00	Neutral ➝ Overweight
RBC RBC Bearings	Upgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$225.93 -0.1%		Neutral ➝ Overweight
RBLX Roblox	Upgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.46 -21.9%		Neutral ➝ Outperform
REAL RealReal	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.50 +15.2%	$2.00 ➝ $3.00
REAL RealReal	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.50 +15.2%	$2.75 ➝ $3.25
RGA Reinsurance Group of America	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$138.31 -1.0%	$170.00 ➝ $162.00
RIVN Rivian Automotive	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$27.00 ➝ $30.00	Outperform
RIVN Rivian Automotive	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$14.00 ➝ $24.00	Equal Weight
RIVN Rivian Automotive	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$30.00 ➝ $32.00	Buy
RIVN Rivian Automotive	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$14.00 ➝ $22.00	Neutral
RIVN Rivian Automotive	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$26.00 ➝ $29.00
RIVN Rivian Automotive	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$40.00 ➝ $44.00	Buy
RIVN Rivian Automotive	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$14.00 ➝ $15.00	Sector Perform
RIVN Rivian Automotive	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.35 -9.9%	$18.00 ➝ $23.00	Neutral
RKLB Rocket Lab USA	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.45 -3.2%	$4.55 ➝ $7.40
RNA Avidity Biosciences	Target Lowered by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.35 +4.7%	$27.00 ➝ $23.00
RPD Rapid7	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.00 +15.6%	$49.00 ➝ $52.00
RVNC Revance Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.22 -8.0%	$48.00 ➝ $41.00
RVNC Revance Therapeutics	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.22 -8.0%	$44.00 ➝ $40.00
SCOR comScore	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.79 +9.8%	$2.50 ➝ $1.50
SCPL SciPlay	Downgraded by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.70 +15.5%		Buy ➝ Neutral
SCPL SciPlay	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.70 +15.5%		Outperform ➝ Neutral
SEAS SeaWorld Entertainment	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.15 -3.0%	$84.00 ➝ $77.00
SEAT Vivid Seats	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.40 +4.5%	$14.00 ➝ $15.00
SEE Sealed Air	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.53 -0.9%	$47.00 ➝ $45.00
SGMO Sangamo Therapeutics	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.05 -7.9%	$11.00 ➝ $9.00
SHAK Shake Shack	Downgraded by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.60 -4.3%		Buy ➝ Neutral
SKWD Skyward Specialty Insurance Group	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.39 +0.0%	$30.00 ➝ $32.00
SMCI Super Micro Computer	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Bryson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$266.13 -23.4%	$65.00 ➝ $250.00	Underperform
SNDR Schneider National	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$30.48 -0.8%	$33.00 ➝ $35.00	Buy
SO Southern	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.19 +0.6%	$72.00	Buy
SOUN SoundHound AI	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.06 +3.5%	$6.20 ➝ $4.20
SOVO Sovos Brands	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.53 +0.0%		Overweight ➝ Neutral
SPLK Splunk	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$99.27 -0.9%	$125.00	Overweight
SQSP Squarespace	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.07 +1.1%	$28.00 ➝ $32.00	Neutral
SQSP Squarespace	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.07 +1.1%	$30.00 ➝ $34.00	Neutral
SSTI SoundThinking	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.89 -19.8%	$30.00 ➝ $22.00
STGW Stagwell	Downgraded by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.72 -11.3%	$11.00 ➝ $8.00	Overweight ➝ Equal Weight
STLA Stellantis	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.12 -1.1%		Buy ➝ Neutral
SYRS Syros Pharmaceuticals	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.73 +1.9%	$16.00 ➝ $11.00
TDG TransDigm Group	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$869.90 -2.1%	$920.00 ➝ $975.00
TDG TransDigm Group	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$869.90 -2.1%	$960.00 ➝ $1,013.00
TDG TransDigm Group	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$869.90 -2.1%	$820.00 ➝ $850.00
TDUP ThredUp	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.06 +26.1%	$2.00 ➝ $3.00
TECH Bio-Techne	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$83.00 -1.5%	$100.00 ➝ $90.00
TERN Terns Pharmaceuticals	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.03 -13.7%	$16.00 ➝ $17.00
TERN Terns Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.03 -13.7%	$11.00 ➝ $8.00
TFII TFI International	Target Raised by	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$131.66 -0.7%	$121.00 ➝ $150.00
TFIN Triumph Financial	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$69.40 +3.3%	$75.00 ➝ $80.00
TGT Target	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$130.60 -0.3%	$165.00 ➝ $135.00	Equal Weight
TMCI Treace Medical Concepts	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.24 -14.4%	$33.00 ➝ $30.00
TOST Toast	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.18 +14.6%	$22.00 ➝ $25.00
TOST Toast	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.18 +14.6%	$30.00 ➝ $31.00
TOST Toast	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.18 +14.6%	$23.00 ➝ $27.00
TPG TPG	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.47 -0.5%	$36.00 ➝ $33.00
TPIC TPI Composites	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.32 +5.0%	$9.00 ➝ $7.00
TTD Trade Desk	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.93 -5.1%	$38.00 ➝ $42.00	Sell
TTWO Take-Two Interactive Software	Target Raised by	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$139.40 -0.5%	$128.00 ➝ $147.00
TWKS Thoughtworks	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.66 -10.6%	$7.00 ➝ $5.00
TWLO Twilio	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.66 +2.2%	$71.00 ➝ $68.00
TWLO Twilio	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.66 +2.2%	$65.00 ➝ $73.00
TWLO Twilio	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.66 +2.2%	$50.00 ➝ $60.00
TWLO Twilio	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.66 +2.2%	$58.00 ➝ $68.00
TWNK Hostess Brands	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.49 +1.2%	$25.00 ➝ $24.00
TWOU 2U	Downgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.05 -28.7%	$12.00 ➝ $4.00	Outperform ➝ Neutral
TWOU 2U	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.05 -28.7%	$7.40 ➝ $5.30
TYGO Tigo Energy	Target Lowered by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.01 -43.6%	$25.00 ➝ $21.00
UFCS United Fire Group	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.99 -0.7%	$20.00 ➝ $19.00
UNM Unum Group	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.95 -1.5%	$56.00 ➝ $58.00
UPS United Parcel Service	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$179.37 -0.7%	$180.00 ➝ $190.00
UPS United Parcel Service	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$179.37 -0.7%	$198.00 ➝ $185.00	Buy ➝ Neutral
UPS United Parcel Service	Downgraded by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$179.37 -0.7%	$210.00 ➝ $195.00	Buy ➝ Hold
UPS United Parcel Service	Target Lowered by	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$179.37 -0.7%	$204.00 ➝ $194.00
UPST Upstart	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.03 -34.2%	$72.00 ➝ $64.00
UTI Universal Technical Institute	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.94 -1.0%	$10.00 ➝ $11.00
VERI Veritone	Downgraded by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.52 -37.0%	$3.50 ➝ $2.00	Neutral ➝ Sell
VRDN Viridian Therapeutics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.26 +2.7%	$46.00 ➝ $39.00
VRDN Viridian Therapeutics	Target Lowered by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.26 +2.7%	$44.00 ➝ $42.00
VTS Vitesse Energy	Downgraded by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.25 -2.3%	$23.00 ➝ $24.00	Outperform ➝ Market Perform
VZIO VIZIO	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.41 -12.0%	$17.00 ➝ $16.00
WE WeWork	Downgraded by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.13 -39.9%		Buy ➝ Neutral
WES Western Midstream Partners	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.34 -2.3%	$31.00 ➝ $29.00	Overweight ➝ Neutral
WHF WhiteHorse Finance	Downgraded by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.67 -3.3%	$13.00	Buy ➝ Neutral
WMG Warner Music Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.07 +1.1%	$30.00 ➝ $33.00
WMG Warner Music Group	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.07 +1.1%	$36.00 ➝ $40.00
WMT Walmart	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$160.91 +0.2%	$170.00 ➝ $175.00	Overweight
WMT Walmart	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$160.91 +0.2%	$175.00 ➝ $190.00
WTW Willis Towers Watson Public	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$202.29 -0.6%	$251.00 ➝ $221.00
XOM Exxon Mobil	Target Raised by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$109.56 +1.7%	$110.00 ➝ $116.00
XOMA XOMA	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.15 +3.2%	$69.00 ➝ $74.00
ZTS Zoetis	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$189.35 +0.0%	$204.00 ➝ $213.00

Always Get the Latest Stock Price Targets and Analyst Ratings: Stay ahead of the market with MarketBeat.com's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register.

This page was last refreshed on Thursday at 04:23 AM ET.

Recent analyst rating Headlines

Moody's Credit Downgrade Dings 2 Bank Stocks
August 8th, 2023 10:59 AM
Bank stocks are under fire today, after Moody's downgraded 10 regional lenders. The analyst warned funding risks and weak profitability will test
Mortgage rates tick higher: 30-year, fixed home loan is at 6.90%; 15-year at 6.25%
August 3rd, 2023 12:06 PM
The average long-term U.S. mortgage rate rose again this week, bad news for Americans seeking to upgrade or buy their first home
The US government's debt has been downgraded. Here's what to know
August 2nd, 2023 5:01 PM
Late Tuesday, Fitch Ratings became the second of the three major credit-rating firms to remove its coveted triple-A assessment of the United States government’s credit worthiness
SoFi Downgraded: Here’s How To Still Make Money
August 2nd, 2023 10:55 AM
Look for the bears to run out of steam around the $9 mark, with a fresh run back above $10 and beyond likely starting shortly after that.
Fitch's U.S. Debt-Rating Downgrade Is Bad News for Stocks. Here's Everything You Need to Know.
August 2nd, 2023 10:35 AM
Investors had been enjoying a nearly perfect year in which the S&P 500 and Nasdaq had racked up massive gains.

More analyst rating Headlines

Top Headlines

All Headlines

Stock Price Targets and Analyst Ratings

Wed., July 5, 2023 | MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Stock Price Targets and Analyst Ratings

Recent analyst rating Headlines

Top Headlines

Stock Price Targets and Analyst Ratings

Key Points

What Are Analyst Ratings?

What Does a Stock Analyst Do?

What Ratings Do Analysts Give?

Buy

Hold

Sell

Underperform

Outperform

Example of an Analyst Rating

How to Use Analyst Ratings

Step 1: Don't rely on a single analyst.

Step 2: Compare analyst ratings across the industry or sector.

Step 3: Consider your own goals and risk tolerance.

Step 4: Don't stubbornly stick to your original assessments.

Why Are Analyst Ratings Important?

How Accurate Are Analyst Ratings?

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

FAQs

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Ratings Reports and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info